Sparen Pharma Private Limited

Sparen Pharma Private Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U13996GJ2013PTC076520 Incorporated 22 August 2013 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company healthcare
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Ahmedabad
ROC office

About Sparen Pharma Private Limited

Data last updated:

Sparen Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 22 August 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U13996GJ2013PTC076520.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Sparen Engineering Services Private Limited. It is led by directors Aashil Jayvant Patel and Saloni Aashil Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 104 Safal Solitaire Corporate Park Nr. Divyabhaskar S.G. Highway Makaraba, Ahmedabad, Gujarat, India – 380051.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U13996GJ2013PTC076520
Registration Number 076520
Incorporation Date 22 August 2013
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Sparen Pharma has one previous CIN (Corporate Identification Number): U28920GJ2013PTC076520. The current CIN is U13996GJ2013PTC076520, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U13996GJ2013PTC076520Current
U28920GJ2013PTC076520Previous

Contact details

Sparen Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 104 Safal Solitaire Corporate Park Nr. Divyabhaskar S.G. Highway Makaraba, Ahmedabad, Gujarat, India – 380051
  • Industry
    Healthcare, Preventive Health Supplements

To see the full contact details of Sparen Pharma Private Limited, buy the company report.

Comprehensive company report
Sparen Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sparen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Sparen Pharma Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sparen Pharma Private Limited, buy the company report.

Board of directors of Sparen Pharma Private Limited

Sparen Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Aashil Jayvant PatelDirector22 Aug 201313 Years 2 MonthsCurrent
Saloni Aashil PatelDirector22 Aug 201313 Years 2 MonthsCurrent

Auditor

Sparen Pharma Private Limited is audited by S H PUJARA & CO for the financial year 2018.

Auditor firmFinancial yearFirm registration number
S H PUJARA & COFY 2018127966W

Shareholding

The shareholding of Sparen Pharma Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sparen Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sparen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Sparen Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Sparen Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Aashil Jayvant Patel was appointed as Director on 22 Aug 2013.

AGM
Sparen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sparen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Aashil Jayvant Patel was appointed as Director.
Appointed
Saloni Aashil Patel was appointed as Director.
Incorporation
22 Aug 2013
Sparen Pharma Private Limited was registered on 22 Aug 2013 with Roc Ahmedabad & aged 13 years 2 months as per MCA records.

Frequently asked questions

Sparen Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 22 August 2013 (13+ years old) and is registered under CIN U13996GJ2013PTC076520.

Sparen Pharma has 2 current directors:

The latest financial statements of Sparen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Sparen Pharma is U13996GJ2013PTC076520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sparen Pharma was incorporated on 22 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Aashil Jayvant Patel was appointed as Director on 22 Aug 2013. Saloni Aashil Patel was appointed as Director on 22 Aug 2013.

The registered office of Sparen Pharma is at B – 104 Safal Solitaire Corporate Park Nr. Divyabhaskar S.G. Highway Makaraba, Ahmedabad, Gujarat, India – 380051.

Sparen Pharma operates in the healthcare industry, in the preventive health supplements segment.

The compliance status of Sparen Pharma is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.

Yes. Sparen Pharma was formerly known as Sparen Engineering Services Private Limited.